Patent · US Active

Cross-linked glycopeptide-cephalosporin antibiotics

US7612037B2 · kind B2 · utility

17Cited by

22References

13Claims

0Family size

Assignee

Theravance, Inc. · US

Inventors

Paul R. Fatheree · San Francisco, US
Martin S. Linsell · San Mateo, US
Daniel D. Long · San Francisco, US
Daniel Marquess · Rue de l'Église, US
Edmund J. Moran · San Francisco, US
Matthew Nodwell · San Francisco, US
S. Derek Turner · Reston, US
James Aggen · Westwood, US

Key dates

Filing date	Oct 25, 2007
Grant date	Nov 3, 2009
Priority date	—
Expiry date	Feb 1, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.